James M. Coghill

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

17h-index1.3kcitations98works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(42), Immunotherapy and Immune Responses(25), T-cell and B-cell Immunology(22), Immune Cell Function and Interaction(22), Chronic Lymphocytic Leukemia Research(12)

Publications98 total

A Tacrolimus Population Pharmacokinetic Model for Adult Allogeneic Hematopoietic Cell Transplant Recipients Provides Clinical Opportunities for Precision Dosing
Clinical Pharmacokinetics·2025
A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD
Blood Advances·2025· 1 citedOpen Access
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study
UNC Libraries·2025Open Access
A randomized, placebo‐controlled first‐in‐human study of oral TQS‐168 in healthy volunteers: Assessment of safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect
Clinical and Translational Science·2024· 1 citedOpen Access
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study
The Lancet Haematology·2024· 21 citedOpen Access
ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Treatment of Respiratory Viral Infections: Results from a Phase 1, First-in-Human, Dose-Ranging Trial
Transplantation and Cellular Therapy·2024· 3 cited
Safety and Efficacy of CD30.CAR-T Cells as Consolidation Post Autologous Transplant in High-Risk CD30 Lymphoma
SSRN Electronic Journal·2024Open Access
ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Treatment of Respiratory Viral Infections: Results from a Phase 1, First-in-Human, Dose-Ranging Trial
Blood·2023· 6 cited
Supplementary Tables 1 - 4, Figures 1 - 2 from Peptide/MHC Tetramer–Based Sorting of CD8<sup>+</sup> T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
2023Open Access
Supplementary Tables 1 - 4, Figures 1 - 2 from Peptide/MHC Tetramer–Based Sorting of CD8<sup>+</sup> T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
2023Open Access
Data from Peptide/MHC Tetramer–Based Sorting of CD8<sup>+</sup> T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
2023Open Access
Data from Peptide/MHC Tetramer–Based Sorting of CD8<sup>+</sup> T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
2023Open Access
Abrogation of Immune Effector Cell Neurotoxicity Syndrome (ICANS) By Rimiducid (RIM) in Patients Treated with CD19-Specific Chimeric Antigen Receptor Modified T-Cells (CAR-T) Engineered with an Inducible Caspase 9 (iC9 CAR.19)-Clinical and Pharmacodynamic Correlates
Blood·2022· 3 cited
Conference Author Index
IEEE Transactions on Applied Superconductivity·2022Open Access
Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD
Blood Advances·2021· 16 citedOpen Access
Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity
Blood·2021· 67 citedOpen Access
Attenuation of Acute Graft-versus-Host Disease in the Absence of the Transcription Factor ROR t
UNC Libraries·2020Open Access
Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease: Cellular immune response
UNC Libraries·2020Open Access
Peptide/MHC Tetramer-Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire
UNC Libraries·2020Open Access
Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT
UNC Libraries·2020· 3 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jonathan S. Serody(39), Bruce R. Blazar(18), Thomas C. Shea(18), Paul M. Armistead(15), Stefanie Sarantopoulos(10), William A. Wood(10), Michelle L. West(9), Don A. Gabriel(9), Angela Panoskaltsis‐Mortari(8), Danny Bruce(8), Benjamin G. Vincent(8), Karen P. McKinnon(8), Kamakshi V. Rao(8), Hemamalini Bommiasamy(7), Kenneth A. Fowler(7), Michael Carlson(6), Andrew Sharf(5), Robert Irons(5), Heather E. Stefanski(5), Anastasia Ivanova(5)